Shahrukh Khurshid Hashmi MD

Shahrukh K. Hashmi, M.D., studies cancer survivorship and late effects of blood and marrow transplantation. This includes physical and psychosocial illnesses that result as a late effect of chemotherapy or radiation. The translational aspect of Dr. Hashmi's research focuses on the biology of aging in cancer survivors. Dr. Hashmi's interests also include the development of novel agents for the treatment of graft-versus-host disease.

Hashmi has been at Mayo Clinic for approximately 10 years. He started Mayo Clinic’s first BMT survivorship program. He has served as PI or Co-PI on many industry-sponsored and NIH-sponsored trials.

Hashmi chairs many national or international professional committees/groups including being the chair of the Worldwide Network for Blood and Marrow Transplant’s Nuclear Accident Committee (Geneva, Switzerland), founding chair of the American Society for Blood and Marrow Transplant Society’s Survivorship SIG (Chicago, Illinois), and co-chair of the Center for International Blood and Marrow Transplant Registry’s (CIBMTR) Health Services Committee (Milwaukee, Wisconsin). He is currently the chair of the Department of Hematology/Oncology at the SSMC, Abu Dhabi, UAE; and the chair of the SEHA Oncology Council.